InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
29%
T+90 mean return
-23.3%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Huizinga Robert Bindert, Vice-Président Exécutif. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 11 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €322k. Activity tracked since 11 May 2021. The latest transaction was disclosed on 2 March 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations11 total
8,500 shares0Common StockSEC:0001628280-22-005118:0
95,000 shares@ US$3.200.012% mcap23.4% of flowCommon StockSEC:0001628280-21-020527:0
95,000 shares@ US$3.2023.4% of flowCommon StockSEC:0001628280-21-020527
16,000 shares@ US$2.630.0017% mcap3.2% of flowCommon StockSEC:0001628280-21-019051:0
16,000 shares@ US$2.633.2% of flowCommon StockSEC:0001628280-21-019051
5,000 shares@ US$19.830.0040% mcap7.5% of flowCommon StockSEC:0001628280-21-018595:0
5,000 shares@ US$19.837.5% of flowCommon StockSEC:0001628280-21-018595
5,000 shares@ US$18.300.0037% mcap6.9% of flowCommon StockSEC:0001628280-21-018218:0
5,000 shares@ US$18.306.9% of flowCommon StockSEC:0001628280-21-018218
◇
40,000 shares@ US$3.028.9% of flowCommon StockSEC:0001628280-21-009847
◇
40,000 shares@ US$3.020.0047% mcap8.9% of flowCommon StockSEC:0001628280-21-009847:0
11 of 11 declarations
About Huizinga Robert Bindert
Robert Bindert Huizinga is the Executive Vice President of Research at Aurinia Pharmaceuticals Inc., a biopharmaceutical company. He is responsible for leading research and development initiatives aimed at innovating in the field of medical treatments.
